Related Experiment Video
Updated: Jul 18, 2026

08:59
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
[Amyotrophic lateral sclerosis: differential diagnosis and frontier forms].
1Faculté de Médecine, Université de Genève, Suisse. michel.magistris@hcuge.ch
Revue Neurologique
|November 28, 2006
Summary
Accurate diagnosis of amyotrophic lateral sclerosis (ALS) is crucial, as many conditions can mimic its symptoms. Early and correct diagnosis, supported by electrodiagnosis, is vital for appropriate patient management.
Area of Science:
- Neurology
- Clinical Medicine
Background:
- Amyotrophic lateral sclerosis (ALS) presents with significant clinical heterogeneity, complicating differential diagnosis.
- Early-stage motor disorders can lead to misdiagnosis of ALS, impacting patient prognosis and treatment.
- Several conditions, including multifocal motor neuropathy and cervical myelopathy, mimic ALS and require distinct management strategies.
Framework:
- Differential diagnosis of ALS involves evaluating disorders across the entire motor system, from the cortex to muscles.
- Recognizing syndromes remote from polio and radiation treatments is essential.
- Special attention should be given to early forms of ALS affecting only upper or lower motor neurons.
Implementation:
- Electrodiagnostic studies are critical for assessing peripheral motor neuron involvement and corticospinal tract function.
- Identifying specific electrodiagnostic signs aids in differentiating ALS from mimicking conditions.
- Clinical assessment, electrodiagnosis, and ancillary tests are indispensable for accurate diagnosis.
Implications:
- Correctly diagnosing ALS and its mimics ensures appropriate treatment and prognosis.
- Distinguishing ALS from similar conditions prevents unnecessary or incorrect therapeutic interventions.
- Advancements in diagnostic tools are needed to improve the accuracy of ALS diagnosis and management.
Related Concept Videos
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

